← All companies

ORGO

Organogenesis Holdings Inc.

ORGO Nasdaq Pharmaceutical Preparations EDGAR ↗

$2.34

-0.11 -4.49%

Key statistics

from XBRL data in SEC filings

Market cap

$301M

Revenue (TTM)

$515M

Net income (TTM)

$2.69M

EPS (TTM)

$-0.12

P/E ratio

—

Dividend yield

—

Free cash flow

-$24.5M

Cash

$91.4M

Total assets

$520M

Gross margin

67.6%

52-week range

$2.04 – $7.08

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Director or officer change; Shareholder vote results Jun 16, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 26, 2026 8-K Director or officer change Feb 23, 2026 8-K Entered a material agreement Dec 29, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Regulation FD disclosure; Other events Sep 25, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Entered a material agreement; Results of operations (earnings release) Aug 7, 2025 8-K Director or officer change; Shareholder vote results Jun 24, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 10-K/A Fiscal year ended 2024-12-31 Apr 29, 2025 8-K Regulation FD disclosure Mar 27, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release) Feb 27, 2025 8-K Entered a material agreement Dec 2, 2024 8-K Entered a material agreement; Other events Nov 22, 2024 8-K Entered a material agreement; Triggering event accelerating an obligation; Unregistered sale of equity; Modified rights of security holders; Director or officer change; Amended charter or bylaws; Other events Nov 13, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Director or officer change; Shareholder vote results Jun 21, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release) May 9, 2024 8-K Other events Apr 3, 2024 10-K Fiscal year ended 2023-12-31 Feb 29, 2024 8-K Results of operations (earnings release) Feb 29, 2024 10-Q Quarter ended 2023-09-30 Nov 9, 2023 8-K Results of operations (earnings release) Nov 9, 2023 10-Q Quarter ended 2023-06-30 Aug 9, 2023 8-K Results of operations (earnings release) Aug 9, 2023 8-K Shareholder vote results Jun 16, 2023 10-Q Quarter ended 2023-03-31 May 10, 2023 8-K Results of operations (earnings release) May 10, 2023 10-K Fiscal year ended 2022-12-31 Mar 1, 2023